Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Peng Jun Zhou"'
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 19, Pp 2383-2385 (2020)
Externí odkaz:
https://doaj.org/article/fdc59f9864034079add0d19cf70df75e
Autor:
Peng-Jun Zhou, Ting Huang, Guang-Lei Ma, Ying-Peng Tong, Wen-Xue Chen, Yi Zang, Juan Xiong, Jia Li, Jin-Feng Hu
Publikováno v:
Journal of Natural Products. 86:1251-1260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a296ce141ed5c84db79d0d37a09bb6e9
https://doi.org/10.1021/acs.jnatprod.3c00040
https://doi.org/10.1021/acs.jnatprod.3c00040
Autor:
Dan-dan Xu, Su-hong Chen, Peng-jun Zhou, Ying Wang, Zhen-dong Zhao, Xia Wang, Hui-qing Huang, Xue Xue, Qiu-ying Liu, Yi-fei Wang, Rong Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Many studies have demonstrated that cancer stem cells (CSCs) or tumor-initiating cells (TICs) are responsible for tumor cell proliferation, chemotherapy resistance, metastasis, and relapse in various cancers. We, and others, have previously shown tha
Externí odkaz:
https://doaj.org/article/f8f00f5020bb4c559da021e03d4faf82
Publikováno v:
Chinese Chemical Letters. 33:4264-4268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc5cee84476f79c2a06c9cca62643620
https://doi.org/10.1016/j.cclet.2021.12.009
https://doi.org/10.1016/j.cclet.2021.12.009
Autor:
Dan-dan Xu, Ying Wang, Peng-jun Zhou, Shu-rong Qin, Rong Zhang, Yi Zhang, Xue Xue, Jianping Wang, Xia Wang, Hong-ce Chen, Xiao Wang, Yu-wei Pan, Li Zhang, Hai-zhao Yan, Qiu-ying Liu, Zhong Liu, Su-hong Chen, Hong-yuan Chen, Yi-fei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Acute myeloid leukemia is an aggressive disease characterized by clonal proliferation and differentiation into immature hematopoietic cells of dysfunctional myeloid precursors. Accumulating evidence shows that CD34+CD38- leukemia stem cells (LSCs) ar
Externí odkaz:
https://doaj.org/article/c00f8a2c303c47cf897bc33262c45bb2
Autor:
Peng-Jun Zhou, Minting Liang, Bin Chu, Chaoxi Wu, Haiyue Long, Mengting Lin, Zhong Liu, Zhe Ren, Wang Yifei
Publikováno v:
ACS Applied Materials & Interfaces. 13:36747-36756
The bacterial exopolysaccharide Curdlan has a unique collagen-like triple helical structure and immune-modulation activities. Although there have been several types of Curdlan gels reported for antibacterial or wound healing purposes, none of them ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f7c746a1b38e90cc80ca60ce53ff5c
https://doi.org/10.1021/acsami.1c06603
https://doi.org/10.1021/acsami.1c06603
Autor:
Dan-dan Xu, Peng-jun Zhou, Ying Wang, Yi Zhang, Rong Zhang, Li Zhang, Su-hong Chen, Bi-bo Ruan, Hai-peng Xu, Wu-yu Fu, Chao-zhi Hu, Lu Tian, Jin-hong Qin, Sheng Wang, Xiao Wang, Qiu-ying Liu, Zhe Ren, Xue-qui Gu, Yao-he Li, Zhong Liu, Yi Fei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Proliferation, a key feature of cancer cells, accounts for the majority of cancer-related diseases resulting in mortality. MicroRNAs (miRNAs) plays important post-transcriptional modulation roles by acting on multiple signaling pathways, but the unde
Externí odkaz:
https://doaj.org/article/13d0542b87954cf5a1703a1a118cd2bd
Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation
Autor:
Wang Yifei, Zhiping Wang, Jianping Deng, Zhen Zhang, Chaoxi Wu, Shunqing Tang, Peng-Jun Zhou, Jintao Huang
Publikováno v:
International Journal of Nanomedicine. 15:5083-5095
Background β-glucans are chiral polysaccharides with well-defined immunological properties and supramolecular wrapping ability of its chiral feature. However, the exploitation of chiral properties of these nanoparticles in drug delivery systems was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d12bb0d0e0e61f3dac8987e894a33e2
https://doi.org/10.2147/ijn.s258145
https://doi.org/10.2147/ijn.s258145
Autor:
Su-Hong, Chen, Dan-Dan, Xu, Peng-Jun, Zhou, Yao, Wang, Qiu-Ying, Liu, Zhe, Ren, Zhong, Liu, Xia, Wang, Hui-Qing, Huang, Xue, Xue, Ying, Wang, Yi-Fei, Wang
Publikováno v:
Experimental and Therapeutic Medicine. 23
Sorafenib is currently used to treat hepatocellular carcinoma (HCC). However, the development of chemoresistance to sorafenib is a major limitation for sorafenib-based therapy in patients with HCC. In the present study, the effect of the combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc631c3778be39d1c798b9aa1071801e
https://doi.org/10.3892/etm.2022.11156
https://doi.org/10.3892/etm.2022.11156
Publikováno v:
Tetrahedron. 124:133010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1efca7e6715709a63c3b32a80759fe77
https://doi.org/10.1016/j.tet.2022.133010
https://doi.org/10.1016/j.tet.2022.133010